Abstract:e13002 Background: Next generation sequencing (NGS) technologies have already shown numerous advances to revolutionize our understanding of cancer genomic profiling and improve cancer treatments. There have been many NGS data analysis tools available for identification of different genomic alternations including short insertion and deletion (short indel, < 25 bp in general). However, detection of > 100 bp large indel (L-indel) from short reads (generally < 200 bp) remains a huge challenge. L-indels identified in genes like MET and FLT3 have proven a critical implication in cancer treatments. Moreover, there is an urgent need for an algorithm to validate L-indels generated by genomic modification systems like ZFN, TALENs and CRISPR/Cas9. Methods: A novel algorithm was developed for calling L-indels in targeted sequencing data as following: raw reads were first filtered by selecting high-quality ones and correcting wrong bases; a chunk of contig (unitig) was then assembled and aligned to reference genome; lastly, break point information was collected and L-indels were calculated. The algorithm was applied on the reads generated from NA12878 cell line and FFPE samples collected in our lab respectively on the Illumina platform. Validation were performed by PCR and Sanger sequencing. Results: 22 novel exonic L-indels (17 deletions and 5 insertions) were identified with a median size of 1,616 bp (range: 25-6,684 bp) from NA12878 sequencing data and 100% successfully confirmed by Sanger sequencing. In addition, 6 out of 9 reported L-indels were also found with the rest awaiting for further exploration. Strikingly, a 2,446 bp deletion on MSH6, encodes an important component in mismatch repair (MMR) system, was detected on a FFPE sample of a lung cancer adenocarcinoma, which prompted to consideration of MMR deficiency otherwise. Conclusions: We have developed and validated a novel and accurate method for NGS large indels detection dedicated for targeted sequencing data in clinical cancer setting. Equipment of this method will greatly increase the capability of comprehensively understanding genomic alterations from a single NGS-based assay, and provide more information for potential clinical use.

A Comparative Analysis of Read Mapping and Indel Calling Pipelines for Next-Generation Sequencing Data

Performance Evaluation of Indel Calling Tools Using Real Short-Read Data

mInDel: a high-throughput and efficient pipeline for genome-wide InDel marker development

Vindel: a Simple Pipeline for Checking Indel Redundancy

A Novel Approach to Detect Large Indels from Targeted Sequencing Data in Clinical Cancer Setting

Uncovering Missed Indels by Leveraging Unmapped Reads

Comparative evaluation of SNVs, indels, and structural variations detected with short- and long-read sequencing data

DelInsCaller: an Efficient Algorithm for Identifying Delins and Estimating Haplotypes from Long Reads with High Level of Sequencing Errors

Improved Indel Detection Algorithm Based On Split-Read And Read-Depth

Detecting Somatic Insertions/Deletions (indels) Using Tumor RNA-Seq Data

indelPost: harmonizing ambiguities in simple and complex indel alignments

UPS-indel: A Better Approach for Finding Indel Redundancy.

Indels Detection Algorithm Based on Optimal Split-Read Matching

Identification of genomic indels and structural variations using split reads

Ingap: an Integrated Next-Generation Genome Analysis Pipeline

Comparative Analysis For The Performance Of Long-Read-Based Structural Variation Detection Pipelines In Tandem Repeat Regions

RNAIndel: Discovering Somatic Coding Indels from Tumor RNA-Seq Data

A Comparison of Variant Calling Pipelines Using Genome in a Bottle as a Reference

Comparative Analysis for the Performance of Variant Calling Pipelines on Detecting the De Novo Mutations in Humans

UPS-indel: a Universal Positioning System for Indels

Indels: computational methods, evolutionary dynamics, and biological applications